NOVAVAX, INC revenue for the last year amounted to 16.71 B MXN, the most of which — 16.71 B MXN — came from its highest performing source at the moment, Innovative Vaccines, the year earlier bringing 38.66 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought NOVAVAX, INC 16.71 B MXN, and the year before that — 38.66 B MXN.